Photo of Kirsten E. Gillibrand
D United States Senate · New York

Sen. Kirsten E. Gillibrand

Compare
Total votes
1,044
all sessions
Attendance
100%
5 missed
Near the chamber average
With party
96%
of cast votes
Lower than 81% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Higher than 79% of chamber peers
Sponsored
1,667
bills & resolutions
Higher than 79% of chamber peers
Committees
12
assignments
1,667 bills and resolutions

Sponsored bills

Total
1,667
Primary
222
Co-sponsor
1,445
This page
1,667
matching current filters
Co-sponsor S 1923
In committee · Indiana Senate · Co-sponsor
Walter Reed Injury Recovery (WIRe) Act of 2021

Walter Reed Injury Recovery (WIRe) Act of 2021 This bill requires the Department of Defense (DOD) to provide government employees and their family members timely access to Walter Reed National Military Medical Center for assessment if they are determined to be experiencing certain anomalous health conditions. DOD must furnish treatment for the anomalous health condition or related affliction at the National Intrepid Center of Excellence at Walter Reed National Military Medical Center. DOD must also develop a process to ensure that government employees and their family members are afforded timely access to Walter Reed National Military Medical Center.

In committee May 27, 2021 1 co-sponsor
Primary S 1907
In committee · Indiana Senate · Lead sponsor
Clean Water Standards for PFAS Act of 2021

Clean Water Standards for PFAS Act of 2021 This bill directs the Environmental Protection Agency (EPA) to develop requirements and incentives to limit the discharge of perfluoroalkyl and polyfluoroalkyl substances (PFAS) into certain waters of the United States. PFAS are man-made and may have adverse human health effects. A variety of products contain the compounds, such as nonstick cookware or weatherproof clothing. Within two years, the EPA must publish water quality criteria for each measurable perfluoroalkyl substance, polyfluoroalkyl substance, and class of PFAS. The water quality criteria must determine how much of these substances can be present in water before it is likely to harm human health. Within four years, the EPA must publish a final rule that establishes, for each priority industry category specified in the bill, effluent limitations guidelines and standards for the discharge of each measurable perfluoroalkyl substance, polyfluoroalkyl substance, and class of PFAS. Under the Clean Water Act, effluent limitations restrict the quantities, rates, and concentrations of chemical, physical, biological, and other constituents which are discharged from point sources (e.g., a discernible source such as a pipe) into navigable waters, the ocean, or other specified waters. In addition, the EPA must award grants to owners and operators of publicly owned treatment works for implementing the effluent limitations guidelines and standards.

In committee May 27, 2021 0 co-sponsors
Co-sponsor S 1873
In committee · Indiana Senate · Co-sponsor
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021

Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 This bill provides for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types. The Government Accountability Office must report on the resulting utilization and effectiveness of such tests.

In committee May 27, 2021 1 co-sponsor
Co-sponsor S 1913
In committee · Indiana Senate · Co-sponsor
DO NOT Call Act

Deter Obnoxious, Nefarious, and Outrageous Telephone Calls Act of 2021 or the DO NOT Call Act This bill increases and establishes criminal penalties, which include imprisonment for up to one year, for an intentional violation of the prohibition on automated telephone marketing and messaging. In addition, a person may be imprisoned for up to three years for an aggravated violation of such prohibition if the person (1) previously has been convicted of such an offense, (2) initiates a certain high volume of such calls during specified periods of time, (3) commits the offense in the furtherance of a felony, or (4) causes losses of at least $5,000 during any one year period to one or more persons. The bill also increases from $10,000 to $20,000 the fine for intentionally transmitting misleading or inaccurate caller identification information.

In committee May 27, 2021 1 co-sponsor
Co-sponsor S 1912
In committee · Indiana Senate · Co-sponsor
Access to Counsel Act of 2021

Access to Counsel Act of 2021 This bill provides various protections for covered individuals subject to secondary or deferred inspections when seeking admission into the United States. Covered individuals include U.S. nationals, lawful permanent residents, aliens in possession of a visa, returning asylees, and refugees. The Department of Homeland Security shall ensure that a covered individual subject to secondary or deferred inspection has a meaningful opportunity to consult with counsel and certain related parties, such as a relative, within an hour of the start of the secondary inspection and as necessary during the inspection process. The counsel and related party shall be allowed to advocate on behalf of the covered individual, including by providing evidence and information to the examining immigration officer. A lawful permanent resident subject to secondary or deferred inspection may not abandon lawful permanent resident status until the individual has had a meaningful opportunity to seek advice from counsel, unless the individual voluntarily and knowingly waives in writing this opportunity to seek counsel's advice.

In committee May 27, 2021 1 co-sponsor
Co-sponsor S 1915
In committee · Indiana Senate · Co-sponsor
ACE Veterans Act

Access to Contraception Expansion for Veterans Act or the ACE Veterans Act This bill directs the Department of Veterans Affairs to authorize veterans to fill prescriptions for a year's supply of contraceptive pills, transdermal patches, vaginal rings, or other hormonal contraceptive products.

In committee May 27, 2021 1 co-sponsor
Co-sponsor S 1898
In committee · Indiana Senate · Co-sponsor
Affordable Medications Act

Affordable Medications Act This bill revises and expands various requirements relating to prescription drug pricing and affordability.  Specifically, the bill expands financial reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; it also adds reporting requirements for certain nonprofit patient-assistance programs. Further, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate prices for certain prescription drugs under Medicare and requires the Centers for Medicare and Medicaid Innovation within the CMS to test specified models for negotiating drug prices. It also establishes reporting requirements, and corresponding civil penalties for noncompliance, for pharmaceutical companies with respect to spikes in prescription drug prices. The bill establishes an excise tax on prescription drugs subject to price spikes, lessens prescription drug cost-sharing requirements under qualified health plans and group health plans, and modifies requirements for the importation of prescription drugs. It also requires drug manufacturers to provide rebates for drugs dispensed to certain low-income individuals under the Medicare program and limits the time frame that trade agreements are required to provide market exclusivity for biological products. Additionally, the bill (1) requires the Food and Drug Administration to establish a database of generic drugs; (2) modifies other provisions related to generic drugs, prescription drug advertising, disclosure of wholesale acquisition prices, and patent-infringement proceedings; and (3) revises certain time frames and conditions related to drug exclusivity. Finally, it establishes an innovation incentive fund for new or more effective treatments of bacterial infections and establishes the Center for Clinical Research within the National Institutes of Health.

In committee May 27, 2021 1 co-sponsor
Co-sponsor S 1851
In committee · Indiana Senate · Co-sponsor
COAST Anti-Drilling Act

Clean Ocean And Safe Tourism Anti-Drilling Act or the COAST Anti-Drilling Act This bill prohibits the Department of the Interior from authorizing the exploration, development, or production (i.e., offshore drilling) of oil or natural gas in specified planning areas of the Outer Continental Shelf along the Atlantic Coast, including the Straits of Florida.

In committee May 26, 2021 1 co-sponsor
Showing 1,421 to 1,430 of 1,667 bills